Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
Holders of 5% or more of ALVOW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alvotech, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Alvotech on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Alvotech, newest first.
No Schedule 13D or 13G filings on Alvotech are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alvotech shares.
No Form 144 notices for Alvotech are on file.